Resultados de búsqueda

Yale Cancer Center: Houston, TX [sic]. por Bendix J

Ver este registro en EBSCOhost

Research highlights. Research highlights of the 23rd Annual Breast Cancer Symposium, December 6-9, 2000, San Antonio, TX. por Cope DG

Ver este registro en EBSCOhost

Multimodal Tx extends survival in node-positive PCa. por Overmyer M

Ver este registro en EBSCOhost

Use of minimally invasive BPH Tx up significantly. por Tennant S

Ver este registro en EBSCOhost

Urge symptoms, advanced prolapse raise Tx failure. por Tennant S

Ver este registro en EBSCOhost

Clinical Updates. MMC injections may end cycle of contracture Tx failures. por Kerr, Richard R.

Ver este registro en EBSCOhost

Epistaxis, TX-Yah or TX-Nah? por Sheth, Jinal, Spiegel, Rory

Ver este registro en EBSCOhost

FROM BURNOUT TO BUY-IN: TRANSFORMING ONCOLOGY NURSE SUPERVISOR RETENTION. por Stein, Charlene, Nair, Kavitha, Taylor, Kyle, Haley, Cindi

Ver este registro en EBSCOhost

ENHANCING QUALITY OF SPACEOAR TREATMENTS BY CONDUCTING A PATIENT ASSESSMENT & PHYSICIAN COLLABORATION. por Chorney, Lindsay, Sher, David, Cooper, Kaylee, Lynn, Danielle, George, Neethu

Ver este registro en EBSCOhost

TROPHY-U-01 Cohort 4 (C4): Sacituzumab govitecan (SG) in combination with cisplatin (cis) as first-line (1L) therapy, followed by maintenance avelumab plus (+) SG or zimberelimab (... por Ramamurthy, Chethan, Recio-Boiles, Alejandro, Grivas, Petros, Swami, Umang, Loriot, Yohann, Tonelli, Julia, Sierecki, Mitch, Barthélémy, Philippe

Ver este registro en EBSCOhost

Mixed-methods clinical trial to evaluate the feasibility of the CURATE.AI optimised digital cognitive rehabilitation therapeutic (COR-Tx) in patients post brain radiotherapy. por Raczkowska, Marlena N., Remus, Alexandria, Vijayakumar, Smrithi, Kwek, Siong Peng, Lee, V Vien, Tadeo, Xavier, Ng, Grady, Lau, Ni Yin, Leong, Qiao Ying, Chai, Qian Yee, Aliyah, Fatin, Blasiak, Agata, Chia, Wei Tsau David, Asplund, Christopher L., Ho, Dean, Vellayappan, Balamurugan A.

Ver este registro en EBSCOhost

Real-world (RW) treatment (tx) patterns of patients (pts) with higher-risk myelodysplastic syndrome (MDS) in a US RWE database (COTA). por Komrokji, Rami S., Hernandez Donoso, Leyla, Hodzic, Sejla, Owusu, Henry F, Nolan, Kevin, Nourry, Claire, Diez-Campelo, Maria

Ver este registro en EBSCOhost

A real-world evaluation of treatment (Tx) patterns and outcomes of acute myeloid leukemia (AML) induction therapies in the community setting. por Maher, Keri Renee, Brown-Bickerstaff, Cherrishe, Qiu, Ying, McBride, Ali, Liassou, Djibril, Laney, JaLyna, Garretson, Marné, Huggar, David, Gajra, Ajeet, Chen, Jiafan, Hughes, David

Ver este registro en EBSCOhost

Real-world baseline characteristics and first-line (1L) treatment (Tx) in patients (pts) with de novo metastatic castration-sensitive prostate cancer (mCSPC) by disease volume. por Freedland, Stephen J., Hong, Agnes, El-Chaar, Nader N., De Hoedt, Amanda Marie, Kim, Janet, Ramaswamy, Krishnan, Gu, Lin, Polascik, Thomas

Ver este registro en EBSCOhost

Treatment (Tx) patterns, efficacy and safety of eribulin for advanced and heavily pretreated breast cancer (ABC): A single-center, real-world study. por Yang, Jin, Yang, Jiao, Wang, Guangxi, Zhang, Haochen, Zhao, Shidi, Zhao, Xiaoai, Dong, Danfeng, Wang, Le

Ver este registro en EBSCOhost

Real-world efficacy of ribociclib (RIB) + aromatase inhibitor (AI)/fulvestrant (FUL), or endocrine monotherapy (ET), or chemotherapy (CT) as first-line (1L) treatment (tx) in elder... por Decker, Thomas, Brucker, Cosima, Engel, Anne, Fasching, Peter A., Göhler, Thomas, Jackisch, Christian, Janssen, Jan, Köhler, Andreas, Luedtke-Heckenkamp, Kerstin, Lüftner, Diana, van Mackelenbergh, Marion, Marmé, Frederik, Nusch, Arnd, Rautenberg, Beate, Reimer, Toralf, Schmidt, Marcus, Weide, Rudolf, Wimberger, Pauline, Roos, Christian, Wöckel, Achim

Ver este registro en EBSCOhost

Response-adapted therapy (tx) with nivolumab plus brentuximab vedotin (nivo + BV) without autologous hematopoietic cell transplantation (auto-HCT) in children, adolescents, and you... por Harker-Murray, Paul David, Cole, Peter D., Hoppe, Bradford S., Hodgson, David C., Beishuizen, Auke, Garnier, Nathalie, Buffardi, Salvatore, Mascarin, Maurizio, Lissat, Andrej, Akyol, Alev, Crowe, Russell, Li, Ju, Drachtman, Richard A., Kelly, Kara M, Leblanc, Thierry, Daw, Stephen

Ver este registro en EBSCOhost

Interim analyses (IA) of the giredestrant (G), G + abemaciclib (A), and G + ribociclib (R) arms in MORPHEUS Breast Cancer (BC): A phase I/II study of G treatment (tx) combinations... por Oliveira, Mafalda, Sonnenblick, Amir, Rugo, Hope S., Jung, Kyung Hae, Yam, Einav Gal, Hurvitz, Sara A., Hernando, Cristina, Im, Seock-Ah, Breton, Vanessa, Collier, Ann, Schwab, Richard B., Zhu, Jing, Sohn, Joohyuk

Ver este registro en EBSCOhost

Abstracts from the 6th Annual Healthcare Transition Research Consortium Conference, Houston, TX, USA, 2014.

Ver este registro en EBSCOhost

What to do after basal insulin: 3 Tx strategies for type 2 diabetes. por Presswala, Lubaina, Shubrook, Jay

Ver este registro en EBSCOhost